In a patient with iron deficiency anemia and chronic kidney disease (CKD) stage 2, taking Eliquis (apixaban), what are the expected levels of Transferrin Saturation (TSAT) and Total Iron-Binding Capacity (TIBC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Deficiency: Expected TSAT and TIBC Levels

Direct Answer

In iron deficiency, you should expect TSAT to be LOW and TIBC to be HIGH. 1

Understanding the Laboratory Pattern

Transferrin Saturation (TSAT)

  • TSAT is LOW in iron deficiency because there is insufficient iron available to saturate transferrin, the iron transport protein 1, 2
  • In absolute iron deficiency, TSAT falls below 20% in CKD patients (or below 16% in healthy individuals) 1
  • The lower the TSAT, the higher the likelihood that iron deficiency is present 1
  • TSAT reflects iron that is readily available for erythropoiesis 1

Total Iron-Binding Capacity (TIBC)

  • TIBC is HIGH in iron deficiency because the body compensates by producing more transferrin to capture whatever iron is available 1
  • This represents the body's attempt to maximize iron uptake when stores are depleted
  • However, in CKD patients specifically, TIBC may be LOW despite iron deficiency due to malnutrition and inflammation, which suppress transferrin production 3

Special Considerations in CKD Stage 2 Patients

Diagnostic Thresholds

  • Absolute iron deficiency in CKD is defined as TSAT <20% AND ferritin <100 ng/mL 1, 2
  • These thresholds differ from healthy individuals (TSAT <16%, ferritin <12 ng/mL) 4
  • Your patient with CKD stage 2 should be evaluated using the CKD-specific criteria 1

Functional vs. Absolute Iron Deficiency

  • Functional iron deficiency occurs when TSAT <20% but ferritin is elevated (>100 ng/mL), indicating adequate stores but insufficient iron release for erythropoiesis 1, 2
  • This pattern is common in CKD patients receiving erythropoietin-stimulating agents 1
  • Absolute iron deficiency shows both low TSAT (<20%) and low ferritin (<100 ng/mL) 1

Critical Pitfall: TIBC in CKD

A major caveat is that TIBC may be unreliable in CKD patients because:

  • Low TIBC (<200 μg/dL) is associated with hypoalbuminemia and elevated C-reactive protein in CKD 3
  • Malnutrition and inflammation suppress transferrin production, leading to falsely low TIBC despite true iron deficiency 3
  • Therefore, in CKD patients, low serum iron with normal TSAT can still indicate iron deficiency risk when TIBC is suppressed by inflammation 3

Clinical Implications for Your Patient

  • Monitor TSAT and ferritin at least every 3 months to optimize iron status 1
  • The probability of iron deficiency increases as TSAT and ferritin values decrease 1
  • Apixaban use does not directly affect these iron parameters, but any occult bleeding could worsen iron deficiency 1
  • Consider that even with "normal" TSAT (>20%), low serum iron (<70 μg/dL in men, <60 μg/dL in women) still confers anemia risk in CKD patients 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Deficiency and Discordant Laboratory Patterns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.